首页> 美国卫生研究院文献>Therapeutic Advances in Cardiovascular Disease >Effect of losartan combined with amlodipine or with a thiazide on uric acid levels in hypertensive patients
【2h】

Effect of losartan combined with amlodipine or with a thiazide on uric acid levels in hypertensive patients

机译:氯沙坦联合氨氯地平或噻嗪类药物对高血压患者尿酸水平的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hyperuricemia leads to endothelial dysfunction and insulin resistance, and has been associated with diseases such as hypertension. Antihypertensive drugs modify serum uric acid levels, however, few data are available about their combinations on uricemia. In this study we evaluate the effect of two combinations of losartan, with amlodipine or with hydrochlorothiazide, on serum uric acid levels in hypertensive patients.Methods:A total of 60 hypertensive patients were randomized in two groups; group LA received losartan/amlodipine (100/5 mg) once a day, whereas LH group received losartan hydrochlorothiazide (100/12.5 mg) once a day for 3 months. In both groups serum uric acid levels were measured at the beginning and end of the study. Patients were evaluated monthly for blood pressure (BP) and adverse events. Statistical analysis was performed with a two-way analysis of variance (ANOVA) for repeated measures.
机译:高尿酸血症导致内皮功能障碍和胰岛素抵抗,并与高血压等疾病有关。降压药会改变血清尿酸水平,但是关于其与尿毒症组合的数据很少。在这项研究中,我们评估了氯沙坦,氨氯地平或氢氯噻嗪两种组合对高血压患者血清尿酸水平的影响。方法:将60例高血压患者随机分为两组;每组60例。 LA组每天一次接受氯沙坦/氨氯地平(100/5 mg),而LH组每天一次接受氯沙坦氢氯噻嗪(100 / 12.5 mg),持续3个月。两组均在研究开始和结束时测量血清尿酸水平。每月对患者的血压(BP)和不良事件进行评估。统计分析使用双向方差分析(ANOVA)进行重复测量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号